liveBook · Manning

Pairwise ranking loss

As explained in Build AI Drug Discovery Pipelines

Ranking loss is a multilabel metric measuring the fraction of incorrectly ordered positive-negative label pairs.

Pairwise ranking loss evaluates multilabel predictions by checking whether positive labels receive higher scores than negative labels. It penalizes incorrectly ordered label pairs; lower values are better, with 0 as the best achievable result. section 5.4.2

Use ranking loss when multilabel evaluation must consider score ordering, not only final thresholded predictions:

  • Compare models by the average number of incorrectly ordered label pairs. section 5.4.2
  • Interpret lower scores as better ranking performance; zero means no counted ordering errors. section 5.4.2
  • Check calibration when comparing rankings, especially with independent label models, complex models, or imbalanced labels. section 5.4.2

CYP inhibitor prediction

In a multilabel cytochrome P450 inhibition task, one molecule can receive several CYP labels. Ranking loss evaluates whether the model scores its true inhibitor labels above labels that should not apply. section 5.4.2

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines incorrect label-pair ordering and direction of improvement, but does not provide a worked numeric calculation.
Examples
Uses CYP inhibitor labels across CYP2C19, CYP2D6, CYP3A4, CYP1A2, and CYP2C9.
What it assumes
Assumes multilabel classification, predicted label scores, and distinction between ranking metrics and classwise F1.
What you can do after
Evaluate multilabel models with Scikit-learn's label_ranking_loss and interpret lower values as better.
How it connects
Connects multilabel classification with coverage error, precision, recall, F1, calibration, and micro- or macro-averaging.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.